Mesenchymal stem cell secretome: Cell-free therapeutic strategy in regenerative medicine

32Citations
Citations of this article
136Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Mesenchymal stem (stromal) cells (MSCs) have a multipotent character, able to differentiate into several cell types, thus MSC serve as a cell reservoir for regenerative medicine. MSC therapeutic potency more associated to their immunosuppressive and anti-inflammatory properties rather than the multipotency, by its mechanism to secrete soluble factors with paracrine actions. Content: MSC paracrine function was known to mediated partly by extracellular vesicles (EVs), which were released predominantly from the endosomal compartment contained in MSC secretome. EV contain a cargo bring micro RNA (miRNA), messenger RNA (mRNA), and proteins from their cells of origin, propose EV as a novel alternative to whole cell therapies, regarding the benefit of EV in safety and easier storage compared to the parent cells. Sumary: The discovery of EVs including exosomes in MSC secretome as key of stem cells beneficial function lead to the future hope of using cell-free regenerative therapies.

Cite

CITATION STYLE

APA

Meiliana, A., Dewi, N. M., & Wijaya, A. (2019). Mesenchymal stem cell secretome: Cell-free therapeutic strategy in regenerative medicine. Indonesian Biomedical Journal. Prodia Education and Research Institute. https://doi.org/10.18585/inabj.v11i2.839

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free